Advanced search
Publication Cover
Cell Cycle Volume 10, 2011 - Issue 22
Submit an article Journal homepage
519
Views
4
CrossRef citations to date
0
Altmetric
Extra Views

Proteasome inhibitors suppress expression of NPM and ARF proteins

Bulbul Pandit Department of Medicine; University of Illinois at Chicago; Chicago, IL USA
&
Andrei L. Gartel Department of Medicine; University of Illinois at Chicago; Chicago, IL USA; Department of Biochemistry and Molecular Genetics; University of Illinois at Chicago; Chicago, IL USA; Department of Microbiology and Immunology; University of Illinois at Chicago; Chicago, IL USACorrespondence[email protected]
Pages 3827-3829 | Received 20 Sep 2011, Accepted 23 Sep 2011, Published online: 15 Nov 2011

References

  • Hochstrasser M. Protein degradation or regulation: Ub the judge. Cell 1996; 84:813 - 815; PMID: 8601303; http://dx.doi.org/10.1016/S0092-8674(00)81058-2
  • Voges D, Zwickl P, Baumeister W. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu Rev Biochem 1999; 68:1015 - 1068; PMID: 10872471; http://dx.doi.org/10.1146/annurev.biochem.68.1.1015
  • Rubenstein EM, Hochstrasser M. Redundancy and variation in the ubiquitin-mediated proteolytic targeting of a transcription factor. Cell Cycle 2010; 9:4282 - 4285; PMID: 20980825; http://dx.doi.org/10.4161/cc.9.21.13741
  • Shabek N, Ciechanover A. Degradation of ubiquitin: the fate of the cellular reaper. Cell Cycle 2010; 9:523 - 530; PMID: 20107325; http://dx.doi.org/10.4161/cc.9.3.11152
  • Adams J. Proteasome a suitable antineoplastic target. Nat Rev Cancer 2004; 4:349 - 360; PMID: 15122206; http://dx.doi.org/10.1038/nrc1361
  • Adams J, Kauffman M. Development of the proteasome inhibitor Velcade (Bortezomib). Cancer Invest 2004; 22:304 - 311; PMID: 15199612; http://dx.doi.org/10.1081/CNV-120030218
  • Duensing S, Duensing A. Bortezomib: killing two birds with one stone in gastrointestinal stromal tumors. Oncotarget 2010; 1:6 - 8; PMID: 21293050
  • Pandit B, Gartel AL. Thiazole antibiotic thiostrepton synergize with bortezomib to induce apoptosis in cancer cells. PLoS ONE 2011; 6:17110; PMID: 21365012; http://dx.doi.org/10.1371/journal.pone.0017110
  • Neznanov N, Komarov AP, Neznanova L, Stanhope-Baker P, Gudkov AV. Proteotoxic stress targeted therapy (PSTT): induction of protein misfolding enhances the antitumor effect of the proteasome inhibitor bortezomib. Oncotarget 2011; 2:209 - 221; PMID: 21444945
  • Fulda S. Novel insights into the synergistic interaction of Bortezomib and TRAIL: tBid provides the link. Oncotarget 2011; 2:418 - 421; PMID: 21789791
  • Bhat UG, Halasi M, Gartel AL. FoxM1 is a general target for proteasome inhibitors. PLoS ONE 2009; 4:6593; PMID: 19672316; http://dx.doi.org/10.1371/journal.pone.0006593
  • Bhat UG, Halasi M, Gartel AL. Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells. PLoS ONE 2009; 4:5592; PMID: 19440351; http://dx.doi.org/10.1371/journal.pone.0005592
  • Pollice A, Sepe M, Villella VR, Tolino F, Vivo M, Calabrò V, et al. TBP-1 protects the human oncosuppressor p14ARF from proteasomal degradation. Oncogene 2007; 26:5154 - 5162; PMID: 17334400; http://dx.doi.org/10.1038/sj.onc.1210313
  • Korgaonkar C, Hagen J, Tompkins V, Frazier AA, Allamargot C, Quelle FW, et al. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function. Mol Cell Biol 2005; 25:1258 - 1271; PMID: 15684379; http://dx.doi.org/10.1128/MCB.25.4.1258-71.2005
  • Gartel AL. A new target for proteasome inhibitors: FoxM1. Expert Opin Investig Drugs 2010; 19:235 - 242; PMID: 20074015; http://dx.doi.org/10.1517/13543780903563364
  • Halasi M, Gartel AL. A novel mode of FoxM1 regulation: positive auto-regulatory loop. Cell Cycle 2009; 8:1966 - 1967; PMID: 19411834; http://dx.doi.org/10.4161/cc.8.12.8708

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.